Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
challenge » challenges (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
challenge » challenges (Expand Search)
-
2361
-
2362
-
2363
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2364
-
2365
-
2366
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2367
-
2368
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2369
-
2370
-
2371
-
2372
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2373
-
2374
-
2375
-
2376
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2377
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2378
-
2379
-
2380
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: